Pigweed Allergy: America's Fastest-Growing Superweed as a Pollen Allergen

Pigweed allergy is an IgE-mediated immune response to pollen from Amaranthus species — a genus of weeds in family Amaranthaceae that includes redroot pigweed (Amaranthus retroflexus) and the aggressively invasive Palmer amaranth (Amaranthus palmeri). The major characterized allergen is Ama r 1, an Ole e 1-like protein shared across Amaranthaceae species, with 70–95% sensitization rates among pigweed-allergic patients. Symptoms follow a reliable August-through-October seasonal pattern. Extensive cross-reactivity with Russian thistle, lamb's quarters, and kochia means pigweed allergy is almost always part of a broader Amaranthaceae sensitization pattern rather than an isolated single-species sensitization.

Palmer amaranth is a type of pigweed — one of many Amaranthus species commonly called pigweed. The term pigweed is used loosely for multiple Amaranthus species including redroot pigweed (A. retroflexus), Palmer amaranth (A. palmeri), smooth pigweed (A. hybridus), and others. From an allergy standpoint, Palmer amaranth is the most ecologically significant because it is the fastest-growing, most herbicide-resistant, and most rapidly expanding species in US agriculture. However, it has no species-specific WHO/IUIS allergens — the characterized allergens Ama r 1 and Ama r 2 are from redroot pigweed. Due to Amaranthaceae cross-reactivity, patients sensitized to any pigweed species can be expected to react to Palmer amaranth as well.

Pigweed pollen season runs from August through October across most US regions, with peak production typically in August and September in the Southeast and Midwest where Amaranthus populations are densest. In the southeastern United States — where Palmer amaranth has the highest density — pollen may begin as early as July. In northern regions and newly invaded Midwest territories, August through September is the core season. Climate change and Palmer amaranth's rapid growth rate mean pollen production can begin earlier in warmer years, and the season may extend later before the first killing frost. This August-through-October window coincides with ragweed season, creating a period of maximum combined fall weed pollen burden.

Probably yes. Pigweed and Russian thistle both belong to family Amaranthaceae and contain homologous Ole e 1-like protein allergens — Ama r 1 in pigweed and Sal k 1 in Russian thistle. This shared protein family drives extensive cross-reactive IgE among Amaranthaceae species, meaning sensitization to one species typically produces cross-reactive IgE to related species in the same family. A patient with positive pigweed testing should also be tested for Russian thistle, lamb's quarters, and kochia to characterize the full Amaranthaceae sensitization profile. This cross-reactive profile matters for immunotherapy planning: a single Amaranthus or Salsola extract can provide broad Amaranthaceae family coverage.

Palmer amaranth (Amaranthus palmeri) earned the superweed designation through its combination of extreme growth rate, reproductive capacity, and herbicide resistance. It grows up to 5 inches per day in warm conditions, can reach heights of 6–8 feet, and produces up to 500,000 seeds per plant. It has evolved resistance to six or more herbicide modes of action including glyphosate, making it one of the most difficult-to-control weeds in US agriculture. It has caused billions of dollars in crop losses and is now established across the southeastern US and expanding into the Midwest and Plains. From an allergy perspective, this agricultural crisis directly amplifies the pigweed pollen burden — as Palmer amaranth colonizes new territories, residents in those areas experience worsening fall allergy seasons.

Anaphylaxis from pigweed pollen exposure is not documented in the published medical literature. The severity classification for pigweed pollen allergy is moderate — significant asthma risk during peak season, particularly in agricultural settings, but not systemic anaphylaxis from inhalation. The profilin allergen Ama r 2 mediates food cross-reactivity through a heat-labile mechanism that causes mild oral allergy syndrome, not systemic anaphylaxis. The Ama r 1 Ole e 1-like allergen drives the primary respiratory sensitization. If you experience throat tightening, difficulty breathing, or cardiovascular symptoms during fall weed season, seek emergency care immediately and discuss the presentation with your allergist — any severe systemic reaction warrants evaluation.

Yes. Pigweed allergy can be confirmed by skin prick testing with non-standardized Amaranthus retroflexus extract or by serum IgE testing using ImmunoCAP w14 (redroot pigweed). Because of extensive Amaranthaceae family cross-reactivity, testing the full family panel — w14 (pigweed), w11 (Russian thistle), w10 (lamb's quarters), and w17 (kochia) — alongside w1 (ragweed) provides the complete fall weed sensitization picture needed for immunotherapy planning. No FDA-standardized Amaranthus extract exists, and Palmer amaranth does not have a separate ImmunoCAP code — testing via A. retroflexus serves as the allergen class proxy for all Amaranthus species.

Pigweed allergy treatment follows a stepped approach. First-line: intranasal corticosteroids (fluticasone, mometasone) started before the August season onset, combined with second-generation antihistamines (cetirizine, loratadine) for breakthrough symptoms. For patients with asthma, optimized controller medications are essential before August. Long-term desensitization through allergen immunotherapy — either custom sublingual drops or subcutaneous allergy shots using Amaranthus extract combined with Russian thistle, ragweed, and other confirmed fall sensitizers — is the most effective strategy for reducing the annual fall weed burden. No FDA-approved SLIT tablet exists for any Amaranthaceae species; custom multi-allergen formulations are the available immunotherapy option.

Yes, this is a legitimate concern for patients in the Midwest and Plains regions where Palmer amaranth is actively expanding. As new Palmer amaranth populations establish in previously low-exposure areas, local pollen loads increase. Patients who were previously only mildly affected by fall weed pollen may experience worsening seasons as the Amaranthus pollen burden in their region grows. Annual allergist reassessment is particularly valuable for patients in the actively invaded zone — the appropriate treatment intensity may need to increase as regional exposure increases. Allergen immunotherapy, which produces lasting immune tolerance, offers protection that seasonal medications alone cannot provide against this worsening ecological trend.

Yes — for the food cross-reactivity mediated by Ama r 2 (profilin), cooking eliminates reactions. Profilin is a heat-labile protein that is denatured by cooking, losing the three-dimensional structure that IgE antibodies recognize. Patients with Ama r 2 profilin sensitization who experience oral tingling when eating raw melon, stone fruits, or Apiaceae vegetables will typically tolerate the same foods cooked without symptoms. This is the same mechanism that makes birch-celery OAS cooking-correctable. The mild, cooking-eliminable nature of profilin reactions distinguishes them from the more serious heat-stable LTP reactions seen with mugwort Art v 3 sensitization, which require avoidance of even cooked foods.